Designer drugs

Deaths associated with new designer drug 5-IT

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e5625 (Published 24 August 2012)
Cite this as: BMJ 2012;345:e5625

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. L Nitin Seetohul, lecturer in forensic toxicology1,
  2. Peter D Maskell, lecturer in forensic toxicology1,
  3. Giorgia De Paoli, lecturer in forensic toxicology1,
  4. Derrick J Pounder, professor of forensic medicine1
  1. 1Centre for Forensic and Legal Medicine, University of Dundee, Dundee DD1 4HN, UK
  1. l.n.seetohul{at}dundee.ac.uk

5-IT or 5-API is the common name for a newly emerging designer drug.1 It is a positional isomer of the tryptamine drug α-methyltryptamine and has the chemical structure (1H-indol-5-yl)propan-2-amine. Currently not controlled in Europe, it is covered, however, by the federal analogue acts in the USA2 …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL